{
  "data": {
    "indicator": {
      "slug": "innovative-drug-negotiation-success-rate",
      "name": "Innovative drug negotiation success rate",
      "definition": "Percentage of innovative drugs successfully negotiated for inclusion in the reimbursement drug list.",
      "unit": "percent",
      "scale": "1",
      "default_unit": "percent",
      "default_scale": "1"
    },
    "scale": "1",
    "unit": "percent",
    "region": {
      "code": "CN",
      "name": "China",
      "type": "country"
    },
    "points": [
      {
        "period_start": "2024-01-01",
        "period_label": "2024",
        "value": 90,
        "scale": "1",
        "unit": "percent",
        "value_type": "actual",
        "statistic_id": "stat_7DSPGYME3SEXR5ZB9KQSHVYE51",
        "url": "https://statorigin.org/stat/stat_7DSPGYME3SEXR5ZB9KQSHVYE51",
        "source_org": "State Council",
        "source": {
          "org": "State Council of China",
          "org_short_name": "State Council",
          "document_title": "2024年版国家医保药品目录出炉，新增91种药品——让参保人用上更多新药好药_政策解读_中国政府网",
          "document_url": "https://www.gov.cn/zhengce/202411/content_6989980.htm",
          "locator": "“全球新”的创新药有38种，创历年新高",
          "published_date": null
        }
      }
    ],
    "available_regions": [
      "CN"
    ]
  },
  "meta": {
    "attribution": "Data from StatOrigin (https://statorigin.org), CC BY 4.0. Attribution required.",
    "license": "https://creativecommons.org/licenses/by/4.0/",
    "docs": "https://statorigin.org/docs/api",
    "total": 1
  }
}